Try Fund Library Premium

Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports
  • Portfolio Rebalancer new

Genmab A/S (GMAB : NSD)

Sector: Healthcare

Close
(10-23-2026)
$43.79
Change
$3.79 (9.48%)
Volume 12,896,604
Open $39.84
Day Range $39.64 - $44.34
52 Week Low $23.62
52 Week High $44.34
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $27,327,523,905
Shares Outstanding 624,058,550
Book Value per Share $4.67
Earnings per Share $0.24
Period
Loading......
Loading......

Legend

Genmab A/S

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
October 23, 2026 43.79
$3.79 (9.48%)
October 22, 2026 40.00
$0.43 (1.09%)
October 21, 2026 39.57
$0.50 (1.28%)
October 20, 2026 39.07
$0.57 (1.48%)
October 19, 2026 38.50
$1.50 (4.05%)
October 16, 2026 37.00
-$0.82 (-2.17%)
October 15, 2026 37.82
$0.93 (2.52%)
October 14, 2026 36.89
$0.32 (0.88%)
October 13, 2026 36.57
-$0.80 (-2.14%)
October 12, 2026 37.37
$0.30 (0.81%)
October 09, 2026 37.07
$1.02 (2.83%)
October 08, 2026 36.05
-$0.60 (-1.64%)
October 07, 2026 36.65
-$1.15 (-3.04%)
October 06, 2026 37.80
-$0.68 (-1.77%)
October 05, 2026 38.48
$3.73 (10.73%)
October 02, 2026 34.75
$0.20 (0.58%)
October 01, 2026 34.55
-$1.13 (-3.15%)
September 30, 2026 35.68
$0.11 (0.30%)
September 29, 2026 35.57
$0.21 (0.59%)
September 28, 2026 35.36
$0.04 (0.11%)
September 25, 2026 35.32
$0.49 (1.41%)
September 24, 2026 34.83
$0.08 (0.23%)
September 23, 2026 34.75
-$0.47 (-1.33%)
September 22, 2026 35.22
$0.53 (1.53%)
September 21, 2026 34.69
-$0.05 (-0.14%)
September 18, 2026 34.74
$0.21 (0.59%)
September 17, 2026 34.54
$0.14 (0.39%)
September 16, 2026 34.40
$0.25 (0.73%)
September 15, 2026 34.15
$1.50 (4.59%)
September 14, 2026 32.65
$0.18 (0.55%)

Funds holding this stock

Try Fund Library Premium

Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports
  • Portfolio Rebalancer new